Chapter 38: Tetrahydrofolate, Vitamin B12, and S-Adenosylmethionine

0:00 / 0:00
Report an issue

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replace the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome to the Deep Dive, where we plunge into complex topics and really try to extract the absolute most important insights just for you.

Today, we're tackling a fascinating and, pretty foundational area of biochemistry.

One, carbon metabolism.

Now, that might sound a bit straight out of a textbook, but trust me, it's absolutely central to your health.

Everything from building your DNA to making your brain hum.

Okay, let's unpack this.

We've been diving deep into our source material, Mark's Basic Medical Biochemistry, a clinical approach.

Our mission today is to illuminate the roles of three key players,

tetrahydrofolate, which we'll call FH4, vitamin B12, and S -adenosylmethionine, or SAM.

These aren't just obscure molecules.

They are, you could say, the unsung heroes behind countless biological processes.

We're going to explore what they do, how they crucially work together, and perhaps most importantly, what happens when this intricate system goes awry.

We'll even use some compelling clinical examples to bring it all to life.

Yeah, and what's truly fascinating here is how these seemingly small, almost invisible transfers of single carbon atoms underpin such a vast array of bodily functions.

Think of it as a highly coordinated molecular dance, orchestrated by these crucial co -factors.

When we connect this to the bigger picture,

understanding this system becomes just vital.

It explains everything from why specific vitamins are essential in your diet to how some anti -cancer therapies actually target these pathways, and even the origins of serious developmental issues like neural tube defects.

It really shows how fundamental biochemistry impacts our everyday health.

That's a great way to set the stage.

So let's meet our first major player,

tetrahydrofolate, or FH4.

This compound, derived from the vitamin folate, which many of us know as folic acid, is essentially the body's primary delivery truck for these one carbon units.

Expert, can you tell us a bit more about what these one carbon units actually are and why FH4 is so good at, well, carrying them?

Certainly.

So when we talk about one carbon units, we're referring to single carbon atoms attached to other molecules, but importantly, they're in various lower oxidation states, not like CO2, which is handled by a different system entirely.

FH4 is truly versatile because its unique, flexible structure acts like a kind of molecular hand, perfectly shaped to grab these one carbon units.

It collects them from various sources within the body, like amino acids such as serine, glycine, and histidine, and even simpler compounds.

All these carbons, while attached to FH4, form what we call the one carbon pool.

Ah, okay.

So it's like a central depot for single carbons?

Exactly.

And FH4 can then modify them depending on what the body needs.

Precisely.

While attached to FH4, these carbons can be oxidized or reduced, making FH4 incredibly adaptable.

It can supply a carbon in exactly the right form needed for a particular reaction.

Now here's a critical detail that becomes a real plot twist later on.

Once a carbon has been reduced all the way down to its level -forming N5 -methyl FH4, it cannot be reoxidized.

It's kind of stuck in that form.

This specific point is absolutely central to understanding some major clinical problems we'll discuss.

That sounds like a key piece of information we'll definitely need to remember.

So these one carbon units FH4 carries, what are some of the most vital processes they power in our bodies?

Why should you, the listener, really care about this intricate chemistry?

Well, they're absolutely essential for a whole host of critical biosynthetic reactions.

We're talking about making deoxytimidine monophosphate or DTMP, which is a crucial building block for synthesizing DNA.

FH4 also provides carbon C2 and C8 for constructing purine bases, which are components of both DNA and RNA.

And even simpler conversions like turning the amino acid glycine into serine rely on FH4.

So you should care because FH4 is directly linked to cell division and growth.

It's vital for processes like cell formation, especially in rapidly dividing cells.

That really underscores its fundamental importance.

Right.

And when we think about how we get this vital compound folate, what are its main sources and how does our body actually get its hands on it?

Is it straightforward?

Well, dietary folate is abundant in green leafy vegetables, fruits, legumes, liver and yeast.

So good sources there.

However, a significant caveat is that extended cooking can destroy, I mean, really destroy a large portion of its content, up to 90 % sometimes.

Wow.

Okay.

When you ingest dietary folate, it's often in a longer polyglutamate form.

Enzymes in your small intestine called conjugases have to cleave off those extra glutamates to produce monoglutamates.

Oh, so it needs processing first.

Exactly.

Those are the forms that can be absorbed.

Once in the intestinal cells, they're primarily converted to N5 methyl FH4 and transported to the liver.

And the liver actually stores about half of your body's total folate, often enough to last for several months before deficiency might show up.

This whole absorption pathway has clear clinical implications.

Let's consider Jean T, an alcoholic patient who developed megaloblastic anemia.

Her serum folic acid was very low, 3 .1 in GML when the reference is 615, and her red blood cells were abnormally large, MCV of 108.

This case clearly illustrates how inadequate dietary intake, often combined with alcohol's damaging effect on intestinal cells, impairs absorption and leads straight to folate deficiency.

Another fascinating, though thankfully rare example is hereditary folate malabsorption.

This is a genetic condition where a crucial transporter protein, PCFT, doesn't function correctly.

Right.

It leads to systemic folate deficiency, anemia, diarrhea, and immune issues in newborns.

The good news, though, is that high -dose oral folate can effectively treat this as it seems to utilize an alternative transporter pathway.

It's amazing how a single nutrient deficiency can have such widespread effects, and I understand these pathways are also targets for certain medications.

That seems important too.

Absolutely.

This pathway is a prime target for specific drugs.

For instance, you have sulfa drugs.

They're analogs of paraminophenzoic acid.

They work by blocking bacterial folate synthesis, something bacteria do, but humans can't.

So they specifically target bacteria without harming our cells.

Very clever.

Then there's methotrexate, a really powerful anti -cancer drug.

It's a folate analog that directly inhibits dihydrofolate reductase, or DHFR.

The enzyme that regenerates FH4, right?

Exactly.

The one responsible for regenerating active FH4.

By preventing FH4 regeneration, methotrexate effectively blocks DNA synthesis.

This is particularly devastating to rapidly dividing cancer cells, which need lots of DNA.

This mechanism is quite similar to how 5 -FU, another anti -metabolite used in chemotherapy, works like in the case of Clark T.

mentioned in the source.

5 -FU is a pyrimidine analog that blocks the critical conversion of D -DUMP to D -DTMP, another crucial DNA building block step leading to what's known as Feynman -less death in tumor cells.

That's a powerful example of how understanding these biochemical pathways can lead to, well, life -saving treatments.

Now you mentioned earlier once FH4 reduces a carbon to its methyl form and 5 -methyl FH4, it can't be reoxidized.

That sounded like a bit of a dead end.

What's the key that unlocks that trapped methyl group?

Does it just stay stuck?

Ah, no.

And that brings us perfectly to our next crucial player,

vitamin B12, also known as cobalamin.

Okay, B12.

That's an excellent question, and it really highlights the crucial partnership here.

Vitamin B12 is truly unique.

Its structure features a distinctive corrin ring with a central cobalt atom.

It's this cobalt that actually gives it its pinkish hue and allows it to bond directly with a carbon atom, which is pretty unusual in biology.

Now, despite its structural complexity and the, frankly, quite long journey needed to absorb it, B12 is involved in only two known reactions in the human body.

Just two?

Really?

That's two.

Yeah.

But both are incredibly fundamentally important, especially that one that releases the trapped methyl group from FH4.

Only two reactions, yet so vital.

Okay, so where do we get this indispensable vitamin, B12, and what's its journey through our body like?

Is it simpler than folate?

Not really, no.

Unlike folate, B12 is exclusively produced by bacteria.

This means humans obtain it pretty much only from dietary animal products, meat, eggs, dairy, fish, poultry, seafood, that sort of thing.

This is why strict vegans absolutely must supplement.

There's no reliable plant source.

Got it.

Animal products or supplements?

And its absorption process is quite intricate, making you vulnerable at several points along the way.

When you ingest B12, it first binds to special proteins called R -binders in your saliva and stomach.

Then, in the small intestine, pancreatic enzymes digest those R -binders, and B12 has to bind to intrinsic factor.

Ah, yes,

I've heard of that.

It's a crucial glycoprotein secreted by the parietal cells in your stomach lining.

Without it, you're in trouble.

This B12 intrinsic factor complex then travels all the way down to the very last segment of your small intestine, the terminal ilium.

Specific receptors there grab it and pull it into your cells.

So it's quite a journey.

It is.

Once absorbed, it's transported to tissues, including the liver, which can store a significant amount, often enough to last for three to six years before deficiency symptoms even begin to appear.

Three to six years?

Wow.

Yeah, the body holds onto it quite well.

But this complex absorption process is precisely why we see conditions like pernicious anemia.

That's a common B12 malabsorption issue caused by a deficiency of intrinsic factor itself.

This could be due to a genetic defect, maybe surgical removal of parts of the stomach or ilium, or even simply a natural decline in intrinsic factor production as we age.

Okay, that makes sense.

And even things like pancreatic deficiency or conditions causing high intestinal pH can disrupt B12 absorption.

Think about Beatrice T, a 75 -year -old woman mentioned in the text.

She came in with numbness and tingling in her legs.

Her diet seemed healthy, but labs showed low serum B12.

This is likely due to reduced gastric acid and pepsin efficiency, which often happens with age.

This limits the release of protein -bound B12 from food in the first place.

For someone like Beatrice, treatment might involve either B12 injections or, interestingly,

very high -dose oral B12, which can sometimes overcome the need for intrinsic factor through mass action.

That case really illustrates the fragility of this whole absorption process, especially as we get older.

So let's get to those two crucial reactions that B12 is involved in.

What are they exactly?

Okay.

The first one, and highly relevant to our FH4 discussion, is its role as a methyl transfer partner.

B12 is essential for transferring a The product is methionine.

Ah, so it takes the methyl group FH4 was stuck with.

Precisely.

This reaction, catalyzed by the enzyme methanine synthase, is the only known way that methyl group can lead FH4 in humans.

It essentially unlocks the folate, freeing it up to be regenerated and used for other reactions.

Okay, that's one.

What's the second?

The second reaction is the rearrangement of a molecule called L -methylmalonyl -CoA to suitable CoA.

This might sound obscure, but it's a vital step in metabolizing certain amino acids, like valine and isoleucine and odd chain fatty acids.

It basically helps funnel their breakdown products into the TCA cycle, which is our body's central energy generating pathway.

I see.

So B12 acts as the crucial partner for FH4, especially in the methyl transfer, and also plays its key role in core metabolism.

That leads us perfectly to bring in our third primary methyl group, ATM.

Can you elaborate on that?

Is that accurate?

Huh.

Yeah, that analogy is quite apt, actually.

SAM is produced from methionine, the amino acid we just mentioned, and ATP, the energy currency, and it acts as the body's universal methyl donor.

It's incredibly active, involved in, believe it or not, over 35 different reactions in humans.

Wow, over 35.

Yeah, donating methyl groups to oxygen or nitrogen atoms in all sorts of different acceptor compounds.

The sheer breadth of its impact is remarkable.

Think about what receives methyl groups from SAM.

You've got creatine, vital for muscle energy, phosphatidylcholine, a key component of cell membranes, epinephrine, a critical hormone in neurotransmitter, melatonin, important for sleep cycles, and even methylated nucleotides and histones, which play a huge role in controlling gene expression that's epigenetics and DNA function itself.

So this has vast implications for cell signaling, membrane integrity, brain function, you name it.

Since donating methyl groups left, right, and center, what happens after it gives one away?

Good question.

After SAM donates its methyl group, it forms S -adendylsilomocysteine, or SAH.

SAH is then quickly hydrolyzed, broken down to homocysteine and adenosine.

And this

homocysteine, well, it needs to be regenerated back to methionine to keep the cycle going.

And how does that happen?

Primarily using that B12 and FH4 -dependent reaction we just talked about.

Ah, so it all links back.

SAM provides the methyl groups, uses methanine, produces homocysteine, and then B12 and FH4 are needed to turn that homocysteine back into methionine so more SAM can be made.

You've got it.

It's a tightly interconnected cycle.

Okay, so we've met each of our main characters, FH4, the carbon carrier, vitamin B12, the methyl transfer partner and metabolic enzyme cofactor, and SAM, the universal methyl donor.

Now let's really connect the dots and explore their incredibly tight -knit relationship.

It's clear that the entire system is built on a delicate balance.

What happens when that balance is disrupted?

Right.

And this brings us to a truly crucial concept, something really important to grasp, known as the methyl trap hypothesis.

The methyl trap.

Okay, remember how we said N5 -methyl -FH4 is very stable and can only donate its methyl group to vitamin B12 in that methanine -synthase reaction.

Yeah, it's stuck otherwise.

Exactly.

So if you have a B12 deficiency or even a defective methanine -synthase enzyme for genetic reasons,

that N5 -methyl -FH4 starts to pile up.

It accumulates.

This deceptively traps most of the body's available folate in this unusable form.

It can't be converted back to other FH4 forms needed for, say, DNA synthesis.

So you end up with a functional folate deficiency.

Even if your total folate levels in the body might appear normal if you measure them, the carbons just can't be released from the folate to do their jobs.

Wow.

So a B12 deficiency can essentially cause a folate problem, functionally speaking.

That's a powerful insight.

What are the clinical consequences of this trap, then?

A key clinical outcome of both actual folate deficiency and this functional folate deficiency caused by B12 issues is something called megaloblastic anemia.

Megaloblastic anemia.

Right.

This is when rapidly dividing cells, especially your blood cell precursors in the bone marrow, can't synthesize DNA properly and therefore can't divide correctly.

What happens, in short, is that you get a decrease in DTMP and purine precursors, the building blocks for DNA.

This leads to an imbalance,

specifically too much DTTP relative to DTTP.

Your cell, which normally belongs in RNA, gets mistakenly incorporated into DNA.

Repair enzymes try to fix it, but because there isn't enough DTTP available, the repair process stalls, DNA replication gets blocked, and the cells get stuck.

This results in these abnormally large, immature blood cells called megaloblasts, which have these weird dysfunctional nuclei.

Ultimately, this causes anemia because these cells don't function properly and die prematurely.

We saw this with Gene T's anemia.

Exactly.

It's also a component often seen, though not the only symptom, in Beatrice T's B12 deficiency.

Another significant concern standing from disruptions in this whole homocysteine methionine cycle is hyperhomocysteine, basically elevated homocysteine levels in the strongly linked to both cardiovascular and neurologic disease.

Homocysteine can accumulate for several reasons we've touched on.

A deficiency in vitamin B12, obviously, because that blocks its conversion back to methionine.

A deficiency in folate, specifically the N5 -methyl -FH4 needed for that reaction.

Sometimes mutations in key enzymes.

A common one is in N5010 -methylene -FH4 reductase.

There's a well -known variant, the C677T mutation, which makes the enzyme less effective, reducing N5 -methyl -FH4 production.

Okay.

And also problems in an alternative pathway for homocysteine.

It's conversion to cysteine.

This requires the enzyme cystothenine B synthase and vitamin B6.

So mutations there or B6 deficiency can also cause homocysteine to build up.

So multiple bottlenecks can lead to this problem directly impacting heart and brain health.

Now, of course, we can't talk about folate deficiency without mentioning neural tube defects, can we?

That link seems incredibly important.

Absolutely not.

It's critical.

We most emphasize the strong link between folate deficiency, particularly during early pregnancy, and an increased risk of neural tube defects like spina bifida.

This understanding has led to really critical public health recommendations.

400 micrograms of folic acid daily for all women capable of becoming pregnant.

That's the standard recommendation.

And even higher doses, up to 4 ,000 micrograms per day, are recommended if there's a prior history of a neural tube defect pregnancy.

This crucial understanding has even led to mandated folate fortification of flour and grain products in the US and many other countries, showing the real world public health impact of knowing this biochemistry.

It really does.

Now, this all makes sense.

But I remember you mentioned something crucial earlier.

B12 deficiency has a distinct and serious neurological component that folate alone simply cannot fix.

Why is that?

What makes B12 neurological impact so different and, frankly, scary?

That's a critical distinction, and it's incredibly important clinically.

The neurological dysfunction seen in B12 deficiency symptoms like numbness and tangling, often starting the feet, difficulty walking,

gait disturbance,

cognitive issues like memory loss or confusion, and in severe cases, even dementia or psychosis.

This is due to two main factors that are specific to B12's roles.

Okay, two factors.

First, there's widespread hypomethylation, meaning reduced methylation in the nervous system.

The brain and nerves rely heavily on SAM for all those crucial methylation reactions we talked about.

Methylating DNA, histones, phospholipids, and nerve membranes, neurotransmitters.

Right, the universal methyl donor.

Exactly.

And crucially, unlike the liver, the nervous system lacks an effective alternative pathway to regenerate methionine from homocysteine if B12 isn't available.

The liver has a backup using betaine, but the brain doesn't really have that option, so a B12 deficiency severely impairs SAM production specifically in the nervous system, leading to these widespread methylation defects that disrupt normal nerve function.

I see.

Lack of SAM in the brain is bad news.

What's the second factor?

The second factor is the accumulation of methylmalonic acid, or MMA.

Remember that second B12 -dependent reaction, converting L -methylmalomal -CoA to succinyl -CoA.

Yeah, the metabolic one.

Well, that's blocked due to B12 deficiency.

L -methylmalonyl -CoA builds up, and it gets converted into methylmalonic acid, which also accumulates.

High levels of MMA are thought to interfere with myelin synthesis, the fatty sheath that insulates nerve fibers.

This leads to myelin destabilization and eventual loss, which disrupts nerve signal transmission.

Think of it like stripping the insulation off electrical wires.

Okay, so both impaired methylation and this buildup of MMA contribute to the neurological damage.

That's a really important explanation, and this leads us directly to what you call the therapeutic trap.

Can you explain that danger?

Yes, this is a vital clinical consideration, a potential pitfall.

If you have a patient presenting with megalelastic anemia, and you suspect either folate or B12 deficiency, but you don't definitively diagnose which one it is, if you treat that B12 -deficient patient only with high doses of folate supplements, something interesting happens.

You will partially or even fully correct the anemia.

The extra folate provides enough substrate for the remaining FH4 forms to support some DNA synthesis, allowing the red blood cell precursors to divide more normally.

The blood picture improves.

Okay, so the anemia gets better.

It sounds good.

Sounds good, but it's dangerous, because while the anemia resolves, you have not addressed the underlying B12 deficiency.

The B12 -dependent issues causing the nervous system problems, the lack of SAM, the buildup of MMA are still ongoing.

By masking the anemia, which is often the most obvious early sign, you allow the potentially irreversible neurological damage to progress, sometimes silently, often unchecked, until it's too late.

Oh, I see.

That is a trap.

It is.

That's why it's absolutely vital to correctly diagnose the specific deficiency B12 folate, or sometimes both, before starting treatment, especially with high -dose folate.

In cases like Jean Tease, the alcoholic patient, her B12 levels might also be borderline low due to poor diet and alcohol's effect on absorption.

So even though folate was clearly low, considering B12 status and potentially supplementing both would be crucial to avoid this dangerous therapeutic trap.

It's truly a complex and intertwined web, isn't it, with such high stakes for patient health?

Before we wrap up, maybe it's worth briefly just mentioning that there are other players in one carbon metabolism, even if not central to this particular deep dive.

You mentioned betaine earlier.

Right.

Choline is another nutrient involved.

In the liver, specifically betaine, which comes from choline, can donate a methyl group directly to homocysteine to form methionine.

This uses the enzyme BHMT.

It provides a sort of backup route for methionine regeneration, bypassing the need for folate in B12.

But as I mentioned, this pathway isn't really in the brain or nervous system, which makes the B12 pathway so critical there.

Understood.

A liver -specific backup.

So, wow.

We've journeyed through the intricate world of one -carbon metabolism, meaning FH4, vitamin B12, and SAM.

We've seen how these tiny molecular players are absolutely essential for everything from DNA synthesis and amino acid metabolism right through to the integrity of your neurological health.

And it's become so clear how incredibly interconnected these are.

A deficiency in one, like B12, can literally ripple through the entire system and create a functional deficiency in another, like folate, with serious cascading consequences for your health.

Indeed.

It's quite elegant, but also quite vulnerable.

And this really raises an important question, perhaps for further exploration.

How precisely does the subtle interplay of these cofactors influence fundamental processes like gene expression and cell differentiation beyond just DNA building blocks?

Our source material even briefly touches on emerging research suggesting that folate deficiency might induce changes in things like microRNAs, which can then affect the genes for DNA methyltransferases, ultimately altering methylation patterns across the genome.

This could potentially be another layer contributing to issues like neural tube defects.

It just shows how deep the dive into these supposedly basic biochemical principles can go, revealing really profound implications for health and disease.

It truly reminds us that understanding these biochemical fundamentals is not just academic exercise.

It's a direct pathway to understanding human health at its most intricate and fundamental level.

What a powerful reminder to end on.

Thank you so much for joining us on this deep dive into one carbon metabolism.

We really hope this has given you a useful shortcut to being well informed on FH4, B12, and SAM, and maybe even sparked your curiosity for more.

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

Chapter SummaryWhat this audio overview covers
One-carbon metabolism relies on the coordinated action of three essential cofactors that enable nucleotide synthesis, amino acid interconversion, and epigenetic regulation throughout the body. Tetrahydrofolate, derived from dietary folate after enzymatic reduction, functions as the central one-carbon carrier, accepting single-carbon units from amino acid donors such as serine, glycine, and histidine, as well as from non-protein sources like formate and formaldehyde. These single carbons enter a dynamic metabolic pool where they become available for critical biosynthetic reactions including thymidylate formation required for deoxyribonucleotide synthesis and purine ring construction essential for nucleotide assembly. However, when tetrahydrofolate becomes methylated to N5-methyl tetrahydrofolate, the trapped methyl group cannot readily reenter biosynthetic pathways without vitamin B12 intervention, a situation clinically known as the methyl-trap effect that links folate and B12 metabolism biochemically. Vitamin B12, obtained exclusively from animal products and microbial sources, functions as a coenzyme in two critical enzymatic reactions: methionine synthase uses methylcobalamin to catalyze homocysteine remethylation back to methionine, preserving this amino acid for continued protein synthesis and metabolic activation, while a second B12-dependent enzyme catalyzes the isomerization of methylmalonic coenzyme A to succinyl-CoA within the citric acid cycle. B12 deficiency emerges through multiple mechanisms including pernicious anemia from absent intrinsic factor, gastrointestinal malabsorption disorders, or exclusively plant-based dietary patterns, resulting in megaloblastic anemia, irreversible peripheral neuropathy, and cognitive impairment. S-adenosylmethionine, generated from methionine and ATP through the action of methionine adenosyl transferase, serves as the universal methyl donor for over three hundred cellular methylation reactions that produce creatine, phospholipids, neurotransmitters including epinephrine and melatonin, and histone modifications controlling gene expression. Disrupted methionine metabolism causes accumulated homocysteine in the bloodstream, an independent pathogenic factor increasing thrombotic risk, atherosclerotic progression, and neurological disease. Folate deficiency during pregnancy substantially elevates neural tube defect risk in developing embryos. Clinical applications span antifolate chemotherapy mechanisms for malignancy suppression, diagnostic evaluation of B12 malabsorption through specialized testing, and emerging research into methylated adenosine compounds for psychiatric treatment.

Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.

Support LML ♥